Challenges in the management of an ignored cause of hyperammonemic encephalopathy: pyruvate carboxylase deficiency

被引:3
作者
Kose, Melis Demir [1 ]
Colak, Ruya [2 ]
Ergon, Ezgi Yangin [2 ]
Kulali, Ferit [2 ]
Yildiz, Meral [2 ]
Alkan, Senem [2 ]
Atilgan, Taner [3 ]
Aslan, Fatma [4 ]
Brown, Ruth [5 ]
Brown, Garry [5 ]
Serdaroglu, Erkin [4 ]
Calkavur, Sebnem [2 ]
机构
[1] Izmir Katip Celebi Univ, Sch Med, Dept Pediat, Div Inborn Errors Metab, Ismet Kaptan St, TR-35100 Izmir, Turkey
[2] Behcet Uz Children Training & Res Hosp, Dept Neonatol, Izmir, Turkey
[3] Pamukkale Univ, Fac Med, Dept Neonatol, Denizli, Turkey
[4] Behcet Uz Children Training & Res Hosp, Dept Nephrol, Izmir, Turkey
[5] Oxford Univ Hosp NHS Fdn Trust, Oxford Med Genet Labs, Oxford, England
关键词
anaplerotic treatment; hemodialysis; hemofiltration; hyperammonemia; lactic acidosis; pyruvate carboxylase deficiency; METABOLISM;
D O I
10.1515/jpem-2019-0307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pyruvate carboxylase (PC) deficiency is a rare autosomal recessive disease and provides clinics in three essential phenotypes. Type B PC deficiency is characterized by lactic acidosis and hyperammonemia. We report a Turkish patient who was diagnosed with type B PC deficiency. Despite the application of anaplerotic treatment with biotin, citrate and arginine-aspartate, continuous veno-venous hemodialysis (CVVHD) treatments were applied due to the failure to keep hyperammonemia and lactic acidosis under control. Ammonia values increasing to 860 mu mol/L were observed. A homozygous novel variant was detected in PC gene analyses containing a 12-base pair deletion on exon 8. Although the mutation found was not reported previously, it was accepted as a pathogenic variant due to its presence in a functional region of the protein. In type B PC deficiency, although a high level of ammonia is expected, it rarely exceeds 200 mu mol/L. As far as we know, the present case has the highest ammonia values in the literature. This paper has been shared to highlight to keep PC deficiency in mind regarding the differential diagnosis of hyperammonemia, particularly in the presence of lactic acidosis, and to serve as a model for the use of different modalities in the management process of PC deficiency.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 21 条
[1]  
Ahmad A, 1999, AM J MED GENET, V87, P331, DOI 10.1002/(SICI)1096-8628(19991203)87:4<331::AID-AJMG10>3.0.CO
[2]  
2-K
[3]  
BAAL MG, 1981, DEV MED CHILD NEUROL, V23, P521
[4]  
Bellomo R, 2002, CRIT CARE, V6, P322
[5]   Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoin [J].
Breen, C. ;
White, F. J. ;
Scott, C. A. B. ;
Heptinstall, L. ;
Walter, J. H. ;
Jones, S. A. ;
Morris, A. A. M. .
EUROPEAN JOURNAL OF PEDIATRICS, 2014, 173 (03) :361-366
[6]   Hyperammonemia-induced toxicity for the developing central nervous system [J].
Cagnon, Laurene ;
Braissant, Olivier .
BRAIN RESEARCH REVIEWS, 2007, 56 (01) :183-197
[7]  
de Meirleir L, 2013, HAND CLINIC, V113, P1667, DOI 10.1016/B978-0-444-59565-2.00034-4
[8]  
Ebert D, 2003, J NEUROSCI, V23, P5928
[9]   Pyruvate carboxylase deficiency:: Metabolic characteristics and new neurological aspects [J].
García-Cazorla, A ;
Rabier, D ;
Touati, G ;
Chadefaux-Vekemans, B ;
Marsac, C ;
de Lonlay, P ;
Saudubray, JM .
ANNALS OF NEUROLOGY, 2006, 59 (01) :121-127
[10]   Clinical and biochemical aspects of primary and secondary hyperammonemic disorders [J].
Haeberle, Johannes .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2013, 536 (02) :101-108